DIAGNOS Announces the Resumption of Screening Operations in Saudi Arabia and Conveys Congratulations to Dr. Salman Abdullah A...
November 12 2020 - 9:30AM
Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK),
(OTCQB: DGNOF), a leader in early detection of critical health
issues through the use of Artificial Intelligence (AI), is pleased
to announce the reopening of the screening clinic in Hafar
al-Batin, a region that includes over 150,000 diabetics for a total
population of over 600,000 people.
Al Kanhoor Medical, Diagnos and its employees
also wish to offer their sincerest congratulations to the Secretary
General of the Health Care Association, Dr. Salman Abdullah
Al-Mutairi, for his assignment as Secretary General of the Council
of Private Associations in the Kingdom. We would also like to note
the great efforts made by Dr. Salman and the Enaya Association, led
by Dr. Abdul Rahman Al-Suwailem, in the retinal examination project
for diabetics in many regions of the Kingdom.
About DIAGNOS
DIAGNOS is a publicly-traded Canadian
corporation with a mission of early detection of critical health
issues through the use of its Artificial Intelligence (“AI”) tool
CARA (Computer Assisted Retina Analysis) to assist doctors, nurses
and specialist in their daily work with diabetics. CARA is a
tele-ophthalmology platform that integrates with existing equipment
(hardware and software) and processes at the point of care. CARA’s
Artificial Intelligence image enhancement algorithms make standard
retinal images sharper, clearer and easier to read. CARA is
accessible securely over the internet, and is compatible with all
recognized image formats and brands of fundus cameras, and is EMR
compatible. CARA is a cost-effective tool for screening large
numbers of patients in real-time. CARA complies with local
regulations, is FDA cleared for commercialization in the United
States of America, is Health Canada licensed for commercialization
in Canada, licensed by the Saudi FDA, COFEPRIS in Mexico and is CE
marking compliant in Europe.
Additional information is available at
www.diagnos.com and www.sedar.com
About Kanhoor Medical Co
Al Kanhoor is focused on selling telemedicine
and AI assisted application in KSA. Al Kanhoor is providing
technology for remote patient observation and marketing Diagnos
suit of products in KSA and beyond. Al Kanhoor is a sister company
of HAJZTELECOM “HTC” Technology & Telecom solutions provider
and contractor to Saudi Telecom - STC- contractor since 1997.
This news release contains forward-looking
information. There can be no assurance that forward-looking
information will prove to be accurate, as actual results and future
events could differ materially from those anticipated in these
statements. DIAGNOS disclaims any intention or obligation to
publically update or revise any forward-looking information,
whether as a result of new information, future events or otherwise.
The forward-looking information contained in this news release is
expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release
For further information, please contact:
Mr. André Larente, President
DIAGNOS Inc.
Tel: 450-678-8882 ext. 224
alarente@diagnos.ca
Diagnos (TSXV:ADK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Diagnos (TSXV:ADK)
Historical Stock Chart
From Apr 2023 to Apr 2024